COVID-19 associated pulmonary embolism: clinical, biochemical and CT imaging findings

1 LODIGIANI C., IAPICHINO G., CARENZO L., CECCONI M., FERRAZZI P., SEBASTIAN T.,et al.; Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020 Jul;191:9-14. Search in Google Scholar

2 KOLLIAS A., KYRIAKOULIS KG., DIMAKAKOS E., POULAKOU G., STERGIOU GS., SYRIGOS K. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020 Jun;189(5):846-847. Search in Google Scholar

3 BIKDELI B., MADHAVAN MV., JIMENEZ D., CHUICH T., DREYFUS I., DRIGGIN E., et al; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973 Search in Google Scholar

4 KLOK FA., KRUIP MJHA., VAN DER MEER NJM., ARBOUS MS., GOMMERS DAMP.J, KANT KM., et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Jul;191:145-147. Search in Google Scholar

5 CUI LY., CHENG WW., MOU ZW., XIAO D., LI YY., LI YJ., et al. Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis. Int J Infect Dis. 2021 Oct;111:154-163. Search in Google Scholar

6 FAUVEL C., WEIZMAN O., TRIMAILLE A., MIKA D., POMMIER T., PACE N., et al; Critical Covid-19 France Investigators. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J. 2020 Jul 1;41(32):3058-3068. Search in Google Scholar

7 TANG N., LI D., WANG X., SUN Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844-847 Search in Google Scholar

8 LLITJOS JF., LECLERC M., CHOCHOIS C., MONSALLIER JM., RAMAKERS M., AUVRAY M., et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020 Jul;18(7):1743-1746. Search in Google Scholar

9 HUANG C., WANG Y., LI X., REN L., ZHAO J., HU Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. Search in Google Scholar

10 GUAN WJ., NI ZY., HU Y., LIANG WH., OU CQ., HE JX., et al; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. Search in Google Scholar

11 DUMEA E., LAZAR M., BARBU EC., CHITU CE., ION DA. Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk. Medicina (Kaunas). 2022 Oct 11;58(10):1436. Search in Google Scholar

12 ACKERMANN M., VERLEDEN SE., KUEHNEL M., HAVERICH A., WELTE T., LAENGER F., et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128 Search in Google Scholar

13 CONTOU D., PAJOT O., CALLY R., LOGRE E., FRAISSÉ M., MENTEC H., et al. Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study. PLoS One. 2020 Aug 27;15(8):e0238413. Search in Google Scholar

14 ORTEGA-PAZ L., TALASAZ AH., SADEGHIPOUR P., POTPARA TS., ARONOW HD., JARA-PALOMARES L., et al. COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment. SeminThrombHemost. 2023 Nov;49(8):816-832. Search in Google Scholar

15 SCHULMAN S., HU Y., KONSTANTINIDES S. Venous thromboembolism in COVID-19.ThrombHaemost 2020;120(12):1642–1653). Search in Google Scholar

16 EDLER C., SCHRÖDER AS., AEPFELBACHER M., FITZEK A., HEINEMANN A., HEINRICH F.,et al. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020 Jul;134(4):1275-1284. Search in Google Scholar

17 GOMEZ CA., SUN CK., TSAI IT., CHANG YP., LIN MC., HUNG IY., et al. Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis. Sci Rep 2021;11(01):16025. Search in Google Scholar

18 MIRO O., JIMENEZ S., MEBAZAA A., FREUND Y., BURILLO-PUTZE G., MARTIN A., et al; Spanish Investigators on Emergency Situations TeAm (SIESTA) network. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J 2021;42(33):3127–3142) Search in Google Scholar

19 HOBOHM L., SAGOSCHEN I., BARCO S., FARMAKIS IT., FEDELI U., KOELMEL S., et al.. COVID-19 infection and its impact on case fatality in patients with pulmonary embolism. Eur Respir J. 2023 Jan 27;61(1):2200619. Search in Google Scholar

20 MONTEIL V., KWON H., PRADO P., HAGELKRÜYS A., WIMMER RA., STAHL M.,et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020 May 14;181(4):905-913.e7. Search in Google Scholar

21 CARSANA L., SONZOGNI A., NASR A., ROSSI RS., PELLEGRINELLI A., ZERBI P., et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two centre descriptive study. Lancet Infect Dis 2020;20(10):1135–1140 Search in Google Scholar

22 DENORME F., VANHOORELBEKE K., DE MEYER SF.. von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke. Front Immunol. 2019 Dec 17;10:2884. Search in Google Scholar

23 CHAUHAN AK., MOTTO DG., LAMB CB., BERGMEIER W., DOCKAL M., PLAIMAUER B., et al. Systemic antithrombotic effects of ADAMTS13. J Exp Med. 2006 Mar 20;203(3):767-76. Search in Google Scholar

24 TAKAYA H., YOSHIJI H., KAWARATANI H., SAKAI K., MATSUMOTO M., FUJIMURA Y., et al. Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure. Biomed Rep. 2017 Sep;7(3):277-285. Search in Google Scholar

25 UEMURA M., FUJIMURA Y., KO S., MATSUMOTO M., NAKAJIMA Y., FUKUI H. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010 Jan;91(1):20-9. Search in Google Scholar

26 NICOLAI L., LEUNIG A., BRAMBS S., KAISER R., WEINBERGER T., WEIGAND M., et al. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy. Circulation. 2020 Sep 22;142(12):1176-1189. Search in Google Scholar

27 SCHURINK B., ROOS E., RADONIC T., BARBE E., BOUMAN CSC., DE BOER HH., et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020 Nov;1(7):e290-e299. Search in Google Scholar

28 VERAS FP., PONTELLI MC., SILVA CM., TOLLER-KAWAHISA JE., DE LIMA M., NASCIMENTO DC., et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020 Dec 7;217(12):e20201129. Search in Google Scholar

29 TOMAZINI BM., MAIA IS., CAVALCANTI AB., BERWANGER O., ROSA RG., VEIGA VC., et al; COALITION COVID-19 Brazil III Investigators. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020 Oct 6;324(13):1307-1316. Search in Google Scholar

30 DEFTEREOS SG., GIANNOPOULOS G., VRACHATIS DA., SIASOS GD., GIOTAKI SG., GARGALIANOS P., et al; GRECCO-19 investigators. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 1;3(6):e2013136. Search in Google Scholar

31 National Institutes of Health (NIH). COVID-19 Treatment Guidelines, Clinical Spectrum of SARS-CoV-2 Infection. 2021. Available online: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ (accessed on 15 March 2024) Search in Google Scholar

32 HASELI S., KHALILI N., BAKHSHAYESHKARAM M., SANEI TAHERI M., MOHARRAMZAD Y. Lobar Distribution of COVID-19 Pneumonia Based on Chest Computed Tomography Findings; A Retrospective Study. Arch Acad Emerg Med. 2020 Apr 18;8(1):e55 Search in Google Scholar

33 TARBOX AK., SWAROOP M. Pulmonary embolism. Int J CritIllnInj Sci. 2013 Jan;3(1):69-72. Search in Google Scholar

34 KERNAN KF., CARCILLO JA. Hyperferritinemia and inflammation. Int Immunol. 2017 Nov 1;29(9):401-409. Search in Google Scholar

35 LEVY MM., FINK MP., MARSHALL JC., ABRAHAM E., ANGUS D., COOK D., et al; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003 Apr;31(4):1250-6. Search in Google Scholar

36 NARAZAKI M., KISHIMOTO T. The Two-Faced Cytokine IL-6 in Host Defense and Diseases. Int J Mol Sci. 2018 Nov 9;19(11):3528. Search in Google Scholar

37 GUL MH., HTUN ZM., DE JESUS PEREZ V., SULEMAN M., ARSHAD S., IMRAN M. et al. Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborative. Respir Res 24, 59 (2023). Search in Google Scholar

38 YOUSAF M., THOMAS MM., ALMUGHALLES S., HAMEED MA., ALHARAFSHEH A., VARIKKODAN I., et al. Pulmonary embolism in COVID-19, risk factors and association with inflammatory biomarkers. Medicine 102(7):p e32887, February 17, 2023. Search in Google Scholar

39 RIYAHI S., DEV H., BEHZADI A., KIM J., ATTARI H., RAZA SI., et al. Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study. Radiology. 2021 Dec;301(3):E426-E433. doi: 10.1148/radiol.2021210777. Epub 2021 Jul 13. PMID: 34254850; PMCID: PMC8294351. Search in Google Scholar

40 SCUDIERO F., SILVERIO A., DI MAIO M., RUSSO V., CITRO R., PERSONENI D. et al., Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome, Thrombosis Research, Volume 198, 2021, ISSN 0049-3848. Search in Google Scholar

41 WEITZ JI., FREDENBURGH JC., EIKELBOOM JW. A Test in Context: D-Dimer. J Am Coll Cardiol. 2017 Nov 7;70(19):2411-2420. Search in Google Scholar

42 YAO Y., CAO J., WANG Q., SHI Q., LIU K., LUO Z., et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020 Jul 10;8:49. Search in Google Scholar

43 LI X., XU S., YU M., WANG K., TAO Y., ZHOU Y., et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020 Jul;146(1):110-118. Search in Google Scholar

44 FIALEK B., PRUC M., SMEREKA J., JAS R., RAHNAMA-HEZAVAH M., DENEGRI A., et al. Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis. Cardiol J. 2022;29(5):751-758. Search in Google Scholar

45 LAZAR M., BARBU EC., CHITU CE., TILISCAN C., STRATAN L., ARAMA SS., et al. Interstitial Lung Fibrosis Following COVID-19 Pneumonia. Diagnostics (Basel). 2022 Aug 22;12(8):2028. Search in Google Scholar

46 LAZAR M., BARBU EC., CHITU CE., ANGHEL AM., NICULAE CM., MANEA ED., et al. Mortality Predictors in Severe SARS-CoV-2 Infection. Medicina (Kaunas). 2022 Jul 18;58(7):945. Search in Google Scholar